Kashiv BioSciences: Funding, Investors & Team (Oct 2026)
Kashiv BioSciences is a fully integrated biopharmaceutical company engaged in the development and manufacturing of complex pharmaceuticals, including biosimilars, applications, and complex generics. The company's infrastructure encompasses research and development facilities in Piscataway, New Jersey; Chicago, Illinois; and Ahmedabad, India, supporting capabilities such as mammalian and microbial cell line development, advanced analytical characterization, and commercial-scale manufacturing. Kashiv's product pipeline includes biosimilar candidates like KSHB002, an abatacept biosimilar that met primary endpoints in a Phase I trial.
Kashiv BioSciences has raised $72.4M across 1 funding round on record, the most recent an undisclosed round of $72.4M announced in Dec 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kashiv BioSciences Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Kashiv BioSciences Funding Rounds
Kashiv BioSciences Founders and Leadership Team
No contact details are on record for this team yet.
Kashiv BioSciences Funding Compared to Other Biotechnology Startups
Kashiv BioSciences' latest round of $72.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kashiv BioSciences in Biotechnology and Piscataway
Companies Similar to Kashiv BioSciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Kashiv BioSciences Funding FAQs
What does Kashiv BioSciences do?
Kashiv BioSciences is a fully integrated biopharmaceutical company engaged in the development and manufacturing of complex pharmaceuticals, including biosimilars, applications, and complex generics. The company's infrastructure encompasses research and development facilities in Piscataway, New Jersey; Chicago, Illinois; and Ahmedabad, India, supporting capabilities such as mammalian and microbial cell line development, advanced analytical characterization, and commercial-scale manufacturing. Kashiv's product pipeline includes biosimilar candidates like KSHB002, an abatacept biosimilar that met primary endpoints in a Phase I trial.
How much funding has Kashiv BioSciences raised?
Kashiv BioSciences has raised $72.4M across 1 round on record. The most recent is an undisclosed round of $72.4M announced in Dec 2025.
When did Kashiv BioSciences last raise funding?
Kashiv BioSciences' most recent funding round on record is an undisclosed round of $72.4M, announced in Dec 2025.
Who founded Kashiv BioSciences?
FundedIQ lists Chintu Patel (Founder) at Kashiv BioSciences.
Where is Kashiv BioSciences headquartered?
Kashiv BioSciences is based in Piscataway, New Jersey, United States.
How many employees does Kashiv BioSciences have?
Kashiv BioSciences is in the 251-500 employee band.
How does Kashiv BioSciences' funding compare to other Biotechnology startups?
Kashiv BioSciences' latest round of $72.4M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kashiv BioSciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kashiv BioSciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.